Franklin Resources’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11M Sell
11,551
-4,277
-27% -$428K ﹤0.01% 2148
2025
Q4
$1.54M Buy
15,828
+4,480
+39% +$384K ﹤0.01% 1906
2025
Q3
$808K Buy
11,348
+1,613
+17% +$107K ﹤0.01% 2216
2025
Q2
$582K Buy
9,735
+1,546
+19% +$84.7K ﹤0.01% 2253
2025
Q1
$430K Buy
8,189
+56
+0.7% +$3.15K ﹤0.01% 2326
2024
Q4
$447K Buy
8,133
+40
+0.5% +$2.1K ﹤0.01% 2337
2024
Q3
$408K Buy
8,093
+36
+0.4% +$1.66K ﹤0.01% 2365
2024
Q2
$354K Buy
8,057
+782
+11% +$33.3K ﹤0.01% 2372
2024
Q1
$320K Sell
7,275
-232
-3% -$10.3K ﹤0.01% 2443
2023
Q4
$356K Buy
7,507
+45
+0.6% +$1.89K ﹤0.01% 2092
2023
Q3
$331K Sell
7,462
-790
-10% -$36.7K ﹤0.01% 2113
2023
Q2
$394K Buy
+8,252
New +$372K ﹤0.01% 2083
2022
Q2
Sell
-6,555
Closed -$294K 2413
2022
Q1
$294K Buy
+6,555
New +$303K ﹤0.01% 2021

Other funds holding IRMD

Franklin Resources's IRMD Position: Q1 2026 in Review

Franklin Resources reduced its iRadimed (IRMD) stake by 27% in Q1 2026, selling an estimated $428K and leaving 11,551 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2148.

Franklin Resources first reported a position in IRMD in Q1 2022 and has held it in 13 quarters since. The position peaked at $1.54M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Franklin Resources held 11,551 shares of iRadimed worth $1.11M as of Q1 2026.
  • Franklin Resources sold 4,277 iRadimed shares in Q1 2026, an estimated $428K.
  • iRadimed made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #2148 holding.
  • Franklin Resources first reported a position in iRadimed in Q1 2022 and has held it in 13 quarters since.
  • Franklin Resources's iRadimed position peaked at $1.54M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.